0001415889-24-006810.txt : 20240305 0001415889-24-006810.hdr.sgml : 20240305 20240305174734 ACCESSION NUMBER: 0001415889-24-006810 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240215 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OLDAKOWSKI MARK CENTRAL INDEX KEY: 0001745566 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38613 FILM NUMBER: 24722779 MAIL ADDRESS: STREET 1: C/O BIONANO GENOMICS, INC. STREET 2: 9540 TOWNE CENTRE DRIVE, SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER NAME: FORMER CONFORMED NAME: Borodkin Mark DATE OF NAME CHANGE: 20180705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bionano Genomics, Inc. CENTRAL INDEX KEY: 0001411690 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 261756290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9540 TOWNE CENTRE DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 888-7600 MAIL ADDRESS: STREET 1: 9540 TOWNE CENTRE DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Bionano Genomics, Inc DATE OF NAME CHANGE: 20190308 FORMER COMPANY: FORMER CONFORMED NAME: BioNano Genomics, Inc DATE OF NAME CHANGE: 20120703 FORMER COMPANY: FORMER CONFORMED NAME: BioNanomatrix Inc DATE OF NAME CHANGE: 20070906 4 1 form4-03052024_100327.xml X0508 4 2024-02-15 0001411690 Bionano Genomics, Inc. BNGO 0001745566 OLDAKOWSKI MARK C/O BIONANO GENOMICS, INC. 9540 TOWNE CENTRE DRIVE, SUITE 100 SAN DIEGO CA 92121 false true false false CHIEF OPERATING OFFICER 0 Common Stock 2024-02-15 4 F 0 1229 1.27 D 48644 D The reporting person is reporting the withholding by the Issuer of an aggregate of 1,229 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 268,058 less shares of common stock. Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023. /s/ Jonathan V. Dixon, Attorney-in-Fact 2024-03-05